Profil
Maureen Deehan is currently Chief Executive Officer at Vivtex Corp.
since 2023 and Independent Director at Adocia SA starting in 2026.
Formerly, Dr. Deehan was Head of Corporate Development & Strategy at Nordic Nanovector ASA. Education includes an undergraduate degree from the University of Strathclyde and a doctorate from the University of Glasgow School of Medicine.
Postes actifs de Maureen Deehan
| Sociétés | Poste | Début |
|---|---|---|
| ADOCIA | Directeur/Membre du Conseil | 18/08/2026 |
Vivtex Corp.
Vivtex Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a drug development company that focuses on Gastrointestinal related diseases using oral oligonucleotide therapeutics | Directeur Général | 21/02/2023 |
Anciens postes connus de Maureen Deehan
| Sociétés | Poste | Fin |
|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | - |
Formation de Maureen Deehan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Strathclyde
University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adocia SA
Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Nordic Nanovector ASA
Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
University of Glasgow School of Medicine
University of Glasgow School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivtex Corp.
Vivtex Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a drug development company that focuses on Gastrointestinal related diseases using oral oligonucleotide therapeutics | Commercial Services |
















